Information for Investigators

Development of the trial database is currently underway, and staff from sites open to recruitment will be notified as soon as the database becomes live.  In the meantime, if you wish to randomise a patient into the GHD Reversal Trial, please contact the Trial Manager directly on 0121 415 9131 or via email.

Newsletters will be added here as soon as they have been circulated to sites.

Individual meetings took place with each Principal Investigator over the course of Spring and Summer 2023. 

Any future meetings will be listed here as soon as they have been booked, and site staff will also be notified via email.

The GHD Reversal Trial protocol was published in Trials on 21st August 2023 and the article can be accessed following the link below:

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-023-07562-z

Guidance documents to support trial processes will be added here as they become available.